An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep

Vaccine

Volumn 14, Issue 12, 1996, Pages 1118-1122

  Kabeya, Hidenori ^a   Ohashi, Kazuhiko ^a   Ohishi, Kazue ^b   Sugimoto, Chihiro ^a   Amanuma, Hiroshi ^b   Onuma, Misao ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b RIKEN TSUKUBA INSTITUTE   (Japan)

Author keywords

Bovine leukaemia virus; Cell mediated immunity; Peptide vaccine; Virus elimination

Indexed keywords

PEPTIDE; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE LEUKEMIA VIRUS; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNOGENICITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SHEEP; VACCINATION;

EID: 0030581326     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00047-3     Document Type: Article

References (29)

1. 1 Mamoun, R.Z., Morisson, M., Rebeyrotte, N. et al. Sequence variability of bovine leukaemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins. J. Virol. 1990, 64, 4180-4188
2. 2 Coulston, J., Naif, H., Brandon, R. et al. Molecular cloning and sequencing of an Australian isolate of proviral bovine leukaemia virus DNA: comparison with other isolates. J. Gen. Virol. 1990, 71, 1737-1746
3. 3 Onuma, M., Hodatsu, T., Yamamoto, S. et al. Protection by vaccination against bovine leukaemia virus infection in sheep. Am. J. Vet. Res. 1984, 45, 1212-1215
4. 4 Merza, M., Söber, J., Sundquist, B., Toots, I. and Morein, B. Characterization of purified gp51 from bovine leukaemia virus integrated into iscom. Arch. Virol. 1991, 120, 219-231
5. 5 Portetelle, D., Limbach, K., Burny, A. et al. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection. Vaccine 1991, 9, 194-200
6. 6 Ohishi, K., Suzuki, H., Yamamoto, T. et al. Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLVenv recombinant: association with cell-mediated immunity. J. Gen. Virol. 1991, 72, 1887-1892
7. 7 Gatei, M.H., Naif, H.M., Kumar, S. et al. Protection of sheep against bovine leukaemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51-70. J. Virol. 1993, 67, 1803-1810
8. 8 Ohishi, K., Suzuki, H., Yasutomi, Y. et al. Augmentation of bovine leukaemia virus (BLV)-specific lymphocyte proliferation responses in ruminants by inoculation with BLVenv-recombinant vaccinia virus: their role in the suppression of BLV replication. Microbiol. Immun. 1992, 36, 1317-1323
9. 9 Sugimoto, M., Ohishi, K. and Ikawa, Y. Role of cell-mediated immunity in bovine leukaemia virus (BLV) infection in ruminants: its implication for the vaccination strategy against retroviruses. Therapeutic Immun. 1994, 1, 297-301
10. 10 Miller, J.M. and Van der Maaten, M.J. Evaluation of an inactivated bovine leukemia virus preparation as an immunogen in cattle. Ann. Rech. Vet. 1978, 9, 971-977
11. 11 Kono, Y., Arai, H., Sentsui, S., Matsukawa, H. and Itohara, S. Protection against bovine leukemia virus infection in sheep by active and passive immunization. Jpn. J. Vet. Sci. 1986, 48, 117-125
12. 12 Reimann, K.A., Tenner-Racz, K., Racz, P. et al. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 1994, 68, 2362-2370
13. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 1994, 68, 6103-6110
14. + cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism. J. Immun. 1994, 153, 4826-4833
15. 15 Gatei, M.H., Good, M.F., Daniel, R.C.W. and Lavin, M.F. T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development. J. Virol. 1993, 67, 1796-1802
16. 16 Callebaut, I., Vonéche, V., Mager, A. et al. Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51. J. Virol. 1993, 67, 5321-5327
17. 17 Böyum, A. Isolation of mononuclear cells granulocytes from human blood. Scand. J. Clin. Lab. Invest. 1968, 97 (suppl), 77-88
18. 18 Ohishi, K., Suzuki, H., Maruyama, T. et al. Induction of neutralizing antibodies against bovine leukosis virus in rabbits by vaccination with recombinant vaccinia virus expressing bovine leukosis virus envelope glycoprotein. Am. J. Vet. Res. 1990, 51, 1170-1173
19. 19 Naif, H.M., Brandon, R.B., Daniel, R.C.W. and Lavin, M.F. Bovine leukaemia proviral DNA detection in cattle using the polymerase chain reaction. Vet. Microbiol. 1990, 25, 117-129
20. 20 Pedersen, N.C., Johnson, L., Birch, D. and Theilen, G.H. Possible immunoenhancement of persistent viremia by feline leukaemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective. Vet. Immun. Immunopathol. 1986, 11, 123-148
21. 21 Siebelink, K.H.J., Tijhaar, E., Huisman, R.C. et al. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J. Virol. 1995, 69, 3704-3711
22. 22 Peris, J.S.M. and Porterfield, J.S. Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines. Nature 1979, 282, 509-511
23. 23 Schlesinger, J.J. and Brandriss, M.W. Growth of 17D yellow fever virus in a macrophage-like cell line, U937: role of Fc and viral receptors in antibody-mediated infection. J. Immun. 1981, 127, 659-664
24. 24 Takeda, A., Tuazon, C.U. and Ennis, F.A. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 1988, 242, 580-583
25. 25 Pahwa, S., Pahwa, R., Saxinger, C., Gallo, R.C. and Good, R.A. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc. Natl Acad. Sci. USA 1985, 82, 8198-8202
26. 26 Weinhold, K.J., Lyerly, H.K., Stanley, S.D., Austin, A.A., Matthews, T.J. and Bolognesi, D.P. HIV-1 gp120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J. Immun. 1989, 142, 3091-3097
27. 27 Viscidi, R.P., Mayur, K., Lederman, H.M. and Frankel, A.D. Inhibition of antigen-induced lymphocyte proliferation by tat protein from HIV-1. Science 1989, 246, 1606-1608
28. 28 Füst, G., Dierich, M.P. and Hidvégi, T. Role of humoral factors in the progression of HIV disease. Immun. Today 1995, 16, 167-169
29. 29 Haraguchi, S., Good, R.A. and Day, N.K. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immun. Today 1995, 16, 595-603